[The genetic bases of the lipid metabolic disorders in atherosclerosis].
The development of dyslipoproteinemia is to a large extent genetically determined. The mutations in gene controlling receptor to lipoproteids of low density, the genes Apo B, Apo A-1, and Apo E have a dominant role in the disturbance of lipid metabolism. The development of atherosclerosis at young age is apparently associated with the mutations in gene of receptors, in the gene Apo B and some mutations in a cluster of the genes A-I--CIII--AIV.